Other
Gross Assets/Liabilities
Boston Scientific Gross Assets/Liabilities decreased by 6.0% to $1.23B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.5%, from $1.05B to $1.23B. Over 5 years (FY 2020 to FY 2025), Gross Assets/Liabilities shows relatively stable performance with a 0.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ4 2015
Last reportedQ1 2026May 1, 2026
How to read this metric
Significant growth in gross figures relative to net figures may indicate increased complexity and potential balance sheet expansion.
Detailed definition
This represents the total carrying value of assets or liabilities before any netting arrangements are applied. It provid...
Peer comparison
Used to compare the scale of operations and the impact of netting policies across different banks.
Metric ID:
gross_assets_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.16B | $1.12B | $1.07B | $1.07B | $966.00M | $942.00M | $1.01B | $1.01B | $1.02B | $977.00M | $1.05B | $986.00M | $974.00M | $1.09B | $990.00M | $1.05B | $1.42B | $1.33B | $1.31B | $1.23B |
| QoQ Change | — | -3.7% | -4.4% | -0.4% | -9.5% | -2.5% | +6.7% | +0.4% | +1.2% | -4.3% | +7.5% | -6.1% | -1.2% | +11.6% | -8.9% | +5.8% | +35.2% | -6.3% | -1.4% | -6.0% |
| YoY Change | — | — | — | — | -16.9% | -15.9% | -6.2% | -5.4% | +5.7% | +3.7% | +4.5% | -2.3% | -4.6% | +11.3% | -5.7% | +6.2% | +45.4% | +22.1% | +32.1% | +17.5% |
Range$942.00M – $1.42B
CAGR+1.2%
Avg YoY Growth+5.7%
Median YoY Growth+4.1%
Current Streak3 quarters decline
Gross Assets/Liabilities at Other Companies
Frequently Asked Questions
- What is Boston Scientific's gross assets/liabilities?
- Boston Scientific (BSX) reported gross assets/liabilities of $1.23B in Q1 2026.
- How has Boston Scientific's gross assets/liabilities changed year-over-year?
- Boston Scientific's gross assets/liabilities increased by 17.5% year-over-year, from $1.05B to $1.23B.
- What is the long-term trend for Boston Scientific's gross assets/liabilities?
- Over 5 years (2020 to 2025), Boston Scientific's gross assets/liabilities has grown at a 0.7% compound annual growth rate (CAGR), from $1.26B to $1.31B.
- What does gross assets/liabilities mean?
- The total value of assets or liabilities before any netting or offsets are applied.